National Amphetamine-Type Stimulant Strategy Background Paper

More documents

Recommendations

Info

160 Drug & Alcohol Services South Australia and South Australia Police. (2006). Guidelines for Safer Dance Parties. Adelaide: Government of South Australia. Drugs and Crime Prevention Committee. (2004). Inquiry into Amphetamine and ‘Party Drug’ Use in Victoria: Final Report. Melbourne: Drugs and Crime Prevention Committee. Drummer, O.H., Gerostamoulous, J., Batziris, H., Chu, M., Caplehorn, J.R.M., Robertson, M.D., & Swann, P. (2003). The incidence of drugs in drivers killed in Australian road traffic crashes. Forensic Science International, 134, 154-162. Duff, C., Johnston, J., Moore, D., & Goren, N. (2007). Dropping, Connecting, Playing and Partying: Exploring the Social and Cultural Contexts of Ecstasy and Related Drug Use in Victoria. Melbourne: Department of Human Services, Victoria. Dundes, L. (2003). DanceSafe and ecstasy: protection or promotion? Journal of Health and Social Policy, 17, 19-37 Dunlop, A. & Tulloch. (2007). Stimulant treatment program: Newcastle update. Presentation at Winter School, Brisbane. Dunn, M., Degenhardt, L., Campbell, G., George, J., Johnston, J., Kinner, S., Matthews, A., Newman, J., & White, N. (2007). Australian Trends in Ecstasy and Related Drug Markets 2006: Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales. Dyer, K.R., & Cruickshank, C.C. (2005). Depression and other psychological health problems among methamphetamine dependent patients in treatment: Implications for assessment and treatment outcome. Australian Psychologist, 40 (2), 96-108. Eggert, L., Thompson, E., Herting, J., Nicholas, L. & Dicker, B. (1994). Preventing adolescent drug abuse and high school dropout through an intensive school-based social network development program. American Journal of Health Promotion, 8(3), 202-215. European Monitoring Centre for Drugs and Drug Addiction. (2001). On-site pill testing interventions in the European Union. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. Enlighten. (2005). http://www.enlighten-hr.org/testingkits.php. Retrieved 13 December 2005. Feeney, G.F.X., Connor, J.P., Young, R.McD., Tucker, J., & McPherson, A. (2006). Improvement in measures of psychological distress amongst amphetamine misusers treated with brief cognitive-behavioural therapy (CBT). Addictive Behaviors, 31 (10), 1833-1843. Fennema, J.S.A., van Ameijden, E.J.C., van den Hoek, A. & Coutinho, R.A. (1997). Young and recent-onset injecting drug users are at higher risk for HIV. Addiction, 92 (11), 1457-1465. Fetherston, J & Lenton, S. (2007). WA Drug Trends 2006: Findings from the Illicit Drug Reporting System (IDRS). NDARC Technical Report No. 268. Sydney: National Drug and Alcohol Research Centre, University of New South Wales. Fleming, P.M. (1998). Prescribing amphetamine to amphetamine users as a harm reduction measure. International Journal of Drug Policy, 9, 339-344.
161 Foerster, A., Lewis, S., Owen, M., & Murray, R. (1991). Pre-morbid adjustment and personality in psychosis. Effects of sex and diagnosis. British Journal of Psychiatry, 158, 171-176. Fowler, G., Kinner, S.A., & Krenske, L. (in press). Containing ecstasy: Analytical tools for profiling an illegal drug market. NDLERF Monograph. Furr, C.D., Delva, J., & Anthony, J.C. (2000). The suspected association between methamphetamine (“ice”) smoking an frequent episodes of alcohol intoxication: Data from the 1993 National Household Survey on Drug Abuse. Drug and Alcohol Dependence, 59, 89-93. Gonsalves, V.M., Sapp, J.L., & Huss, M.T. (2007). A comparison of methamphetamine and nonmethamphetamine users in a dual diagnosis facility. Addiction Research and Theory, 15 (3), 277-284. Gossop, M., Griffiths, P., & Strang, J. (1988). Chasing the dragon: Characteristics of heroin chasers. British Journal of Addiction, 83, 1159-1162. Gowing, L., Henry-Edwards, S., Irving, R., & Ali, R. (2001). Ecstasy: MDMA and other ringsubstituted amphetamines. Produced for the World Health Organisation by Drugs and Alcohol Services Council (DASC); Adelaide: South Australia. Gowing, L.R., Henry-Edwards, S.M., Irvine, R.J., & Ali, R.L. (2002). The health effects of ecstasy: A literature review. Drug and Alcohol Review, 21 (1), 53-63. Grabowski, J., Shearer, J., Merrill, S., & Negus, S. (2004). Agonist-like, replacement and pharmacotherapy for stimulant abuse and dependence. Addictive Behaviours, 29, 1439- 1464. Gray, S.D., Fatovich, D.M., McCoubrie, D.L., Daly, F.F. (2007). Amphetamine related presentations to an inner-city tertiary emergency department: A prospective evaluation. Medical Journal of Australia, 186, 336-339. Green, L (1996). Policing Places with Drug Problems. Thousand Oaks: Sage Publications. Griggs, W., Caldicott, D., Pfeiffer, J., Edwards, N., Pearce, A. & Davey, M. (2007). The impact of drugs on road crashes, assaults and other trauma – a prospective trauma toxicology study. National Drug Law Enforcement Research Fund (NDLERF) Monograph Series No. 20. Commonwealth of Australia. Gruenert, S., Ratnam, S., & Tsantefski, M. (2004). The Nobody’s Clients Project: Identifying and Addressing the Needs of Children with Substance Dependent Parents. Victoria: Odyssey Institute of Studies, Odyssey House. Guillot, C., & Greenway, D. (2006). Recreational ecstasy use and depression. Journal of Psychopharmacology, 20 (3), 411-416. Gutchewsky, C. (2003). Methamphetamine and Child Welfare. Council Blufds, IA: Iowa Department of Human Services.
Page 1:
National Amphetamine-Type Stimulant
Page 4 and 5:
ii Acknowledgments This research wo
Page 6 and 7:
iv Table of contents Acknowledgemen
Page 8 and 9:
vi List of tables Table 1.1: Amphet
Page 10 and 11:
viii
Page 12 and 13:
2 The NDS framework and the Law Enf
Page 14 and 15:
4 Table 1.1: Amphetamine-type stimu
Page 16 and 17:
6 particularly on the Pacific Coast
Page 18 and 19:
8 Figure 1.1: MDMA (ecstasy) tablet
Page 20 and 21:
10 a 10-year period. While some of
Page 22 and 23:
12 Figure 1.4: Forms of methampheta
Page 24 and 25:
14 Figure 1.5: Median purity of met
Page 26 and 27:
16 As noted, the route of administr
Page 28 and 29:
18 Chapter 2: Setting the Context T
Page 30 and 31:
20 Figure 2.2: Prevalence of ecstas
Page 32 and 33:
22 19 years (Dunn et al., 2007). Th
Page 34 and 35:
24 The use of MDMA among police det
Page 36 and 37:
26 this survey is conducted with th
Page 38 and 39:
28 models might be useful. On the o
Page 40 and 41:
30 the questionnaire in February 20
Page 42 and 43:
32 2.5 Summary According to the lat
Page 44 and 45:
34 anxiety, agitation, tremor, teet
Page 46 and 47:
36 may be stronger than the link wi
Page 48 and 49:
38 Srisurapanot and colleagues (200
Page 50 and 51:
40 Psychiatric problems appear to o
Page 52 and 53:
42 In 2005, there was a total of 68
Page 54 and 55:
44 The most recent EDRS survey foun
Page 56 and 57:
46 same reasons they use the drugs
Page 58 and 59:
48 Shoptaw and Reback (2007) review
Page 60 and 61:
50 It has also been speculated that
Page 62 and 63:
52 Parental ATS use In addition to
Page 64 and 65:
54 The Minnesota Department of Heal
Page 66 and 67:
56 Chapter 4: Prevention and Harm R
Page 68 and 69:
58 should cover the full range of d
Page 70 and 71:
60 specific drug (Spoth et al., 200
Page 72 and 73:
62 be applied regularly and systema
Page 74 and 75:
64 Strategies targeting vulnerable
Page 76 and 77:
66 Examples of particular periods t
Page 78 and 79:
68 At-risk workplaces There is incr
Page 80 and 81:
70 The consultation forum with Abor
Page 82 and 83:
72 young people was noted in the su
Page 84 and 85:
74 and/or others); mental health ef
Page 86 and 87:
76 of the fact that frequently peop
Page 88 and 89:
78 Sexual risk behaviour is a furth
Page 90 and 91:
80 • Cleaning up; • Transport o
Page 92 and 93:
82 Assessing the risks of illicitly
Page 94 and 95:
84 4.4 Challenges of applying preve
Page 96 and 97:
86 but a number of studies are now
Page 98 and 99:
88 The pack included a video, train
Page 100 and 101:
90 Chapter 5: Treatment and Service
Page 102 and 103:
92 to the occurrence of amphetamine
Page 104 and 105:
94 In relation to the need for spec
Page 106 and 107:
96 These studies replicate earlier
Page 108 and 109:
98 addressed not only the drug user
Page 110 and 111:
100 Research conducted in the subse
Page 112 and 113:
102 users, data that may be general
Page 114 and 115:
104 that limit brain exposure to me
Page 116 and 117:
106 only significant difference was
Page 118 and 119:
108 through the use of antipsychoti
Page 120 and 121: 110 to develop the capacity of the
Page 122 and 123: 112 It was also suggested that link
Page 124 and 125: 114 as new evidence emerges. New ps
Page 126 and 127: 116 border in 2000 (McKetin et al.,
Page 128 and 129: 118 Table 6.1: Number of clandestin
Page 130 and 131: 120 Table 6.2: Examples of domestic
Page 132 and 133: 122 Tasmania In 2004, strengthened
Page 134 and 135: 124 Recommendations from the consul
Page 136 and 137: 126 Although there are a number of
Page 138 and 139: 128 illegal drugs. When incarcerate
Page 140 and 141: 130 heroin) (Payne et al., 2007). I
Page 142 and 143: 132 Some examples of diversion prog
Page 144 and 145: 134 Other research has compared psy
Page 146 and 147: 136 Rehabilitation in Corrections T
Page 148 and 149: 138 Synthetic Drugs measure will im
Page 150 and 151: 140 • Stealing from motor vehicle
Page 152 and 153: 142 criminal offences There continu
Page 154 and 155: 144 • Increase international coll
Page 156 and 157: 146 • Ensuring offence and penalt
Page 158 and 159: 148 Law enforcement agencies are pl
Page 160 and 161: 150 Appendix 1 National consultatio
Page 162 and 163: 152 Appendix 2 Written submissions
Page 164 and 165: 154 Australian Institute of Health
Page 166 and 167: 156 Bowers, J. & Johnson, S. (2003)
Page 168 and 169: 158 Crits-Christoph, P., Siqueland,
Page 172 and 173: 162 Halkitis, P.N., Parsons, J.T.,
Page 174 and 175: 164 Hull, P., Rawstorne, P., Zablot
Page 176 and 177: 166 Leek, L., Seneque, D., & Ward,
Page 178 and 179: 168 McKetin, R., McLaren, J., Kelly
Page 180 and 181: 170 NSW Health (2006). Psychostimul
Page 182 and 183: 172 Ressler, K.J., & Nemeroff, C.B.
Page 184 and 185: 174 Small, W., Kerr, T., Charette,
Page 186 and 187: 176 United Nations Office for Drug
Page 188 and 189: 178
Page 190: 180
show all

National Amphetamine-Type Stimulant Strategy Background Paper

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?